Literature DB >> 2040939

Current therapy for acute Kawasaki syndrome.

A H Rowley1, S T Shulman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2040939     DOI： 10.1016/s0022-3476(05)82225-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  4 in total

Review 1.  Superantigens related to Kawasaki syndrome.

Authors:  D Y Leung
Journal:  Springer Semin Immunopathol       Date:  1996

2.  Effects of immunoglobulin and gamma-interferon on the production of tumour necrosis factor-alpha and interleukin-1 beta by peripheral blood monocytes in the acute phase of Kawasaki disease.

Authors:  H Suzuki; S Uemura; S Tone; T Iizuka; M Koike; K Hirayama; J Maeda
Journal:  Eur J Pediatr       Date:  1996-04       Impact factor: 3.183

3.  Kawasaki disease in Australia, 1993-95.

Authors:  J A Royle; K Williams; E Elliott; G Sholler; T Nolan; R Allen; D Isaacs
Journal:  Arch Dis Child       Date:  1998-01       Impact factor: 3.791

Review 4.  Vasculitis in childhood.

Authors:  I Roberti; L Reisman; J Churg
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.